Results and effects of patients who have recovered from COVID-19: identifying the relationship with risk factors and comorbidities

Abstract

The number of deaths from COVID-19 is closely associated with multimorbidities. This study aimed to review the clinical and functional conditions of patients who recovered from COVID-19. Additionally, identify the relationship with risk factors and comorbidities. Systemic arterial hypertension (SAH) was more frequently observed in patients with severe COVID-19. Diabetes mellitus (DM) is one of the comorbidities that has contributed the most to the increase in the number of hospitalizations due to complications and the number of deaths due to infection by COVID-19. Obesity has been shown to be a risk factor for hospitalization in patients with COVID-19 under 60 years of age. Most survivors of COVID-19 suffer primarily from muscle fatigue or weakness. In addition, patients who were more seriously ill during their hospital stay have greater impairment of functional capacity, pulmonary diffusion and fatigue symptoms, and are the main target population for long-term recovery interventions. To optimize the post-hospitalization rehabilitation of patients after discharge from COVID-19, the need for multidisciplinary work in rehabilitation, the reinforcement of public policies to ensure equity in access to the public health system and training should be considered of the health team in view of the new demands and realities generated by COVID-19.

Modifiable contributing factors to COVID-19: A comprehensive review

“…For deaths with conditions or causes in addition to COVID-19, on average, there were 4.0 additional conditions or causes per death.”)( https://www.cdc.gov/nchs/nvss/vsrr/covid_weekly/index.htm?fbclid=IwAR3-wrg3tTKK5-9tOHPGAHWFVO3DfslkJ0KsDEPQpWmPbKtp6EsoVV2Qs1Q ). While many comorbidities have been observed, the most frequent tend to be diabetes, hypertension, obesity, and respiratory and renal illnesses ( Almeida et al, 2022 ; Peterfi et al, 2022 . ), with diabetes and hypertension ranking near or at the top in most comorbidity studies ( Shah et al, 2021 ; Shadnoush et al, 2022 ).…”